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Abstract: Endotoxemia plays a major causative role in the myocardial injury and 
dysfunction associated with sepsis. Extracellular hemoglobin (Hb) has been shown to 
enhance the pathophysiology of endotoxemia. In the present study, we examined the 
myocardial pathophysiology in guinea pigs infused with lipopolysaccharide (LPS), a 
Gram-negative bacterial endotoxin, and purified Hb. We also examined whether the 
administration of the Hb scavenger haptoglobin (Hp) could protect against the effects 
observed. Here, we show that Hb infusion following LPS administration, but not either 
insult alone, increased myocardial iron deposition, heme oxygenase-1 expression, 
phagocyte activation and infiltration, as well as oxidative DNA damage and apoptosis assessed 
by 8-hydroxy-2'-deoxyguanosine (8-OHdG) and terminal deoxynucleotidyl transferase dUTP 
nick end labeling (TUNEL) immunostaining, respectively. Co-administration of Hp 
significantly attenuated the myocardial events induced by the combination of LPS and Hb. 
These findings may have relevant therapeutic implications for the management of sepsis 
during concomitant disease or clinical interventions associated with the increased  
co-exposures to LPS and Hb, such as trauma, surgery or massive blood transfusions. 
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1. Introduction 
Myocardial dysfunction and injury are key pathophysiological events in sepsis and septic  
shock [1,2]. Lipopolysaccharide (LPS), a Gram-negative bacterial endotoxin, is a primary mediator of 
the cardiovascular dysfunction associated with sepsis or septic shock [3,4]. The mechanisms 
underlying LPS-mediated cardiovascular dysfunction are multifactorial, but generally implicate the 
overproduction of cytokines (i.e., tumor necrosis factor-alpha, interleukin 1-beta) and reactive 
oxygen/nitrogen species as causative processes [3,4]. 
Several studies have demonstrated that LPS pathophysiology can be exacerbated by extracellular 
hemoglobin (Hb) [5–7]. In mice, intra-peritoneal injection of LPS combined with intravascular 
infusion of purified Hb induced greater mortality compared to Hb or LPS alone [5]. In rabbits, 
intravenous administration of chemically cross-linked Hb and LPS caused significantly greater 
cardiovascular dysfunction and mortality compared to Hb or LPS alone [6]. Murine models of 
infection coupled with a deficiency in heme oxygenase-1 (HO-1), a key enzyme of heme catabolism, 
suggest that the release of heme following hemolysis increases mortality [8]. In humans, the level of 
hemolysis occurring during Gram-negative bacteremia may be associated with an increased risk for 
mortality [9,10]. Plasma Hb levels in these patients were reported to occur over a range of 
concentrations from 10 to 40 mg/dL (equivalent to ~5 to 25 µM as heme) [9,10]. Reduced plasma 
levels of hemopexin and haptoglobin (Hp) also correlated with an increased risk for mortality  
in septicemia [11]. 
Hb enhancement of LPS pathophysiology may be particularly relevant in Gram-negative sepsis 
with concomitant trauma, surgery or blood transfusions when there is an increased likelihood for 
interaction between bacterial cell wall LPS and circulating extracellular Hb. Under such 
circumstances, it is postulated that the therapeutic management of Hb-LPS synergism may 
significantly ameliorate clinical outcomes. Hp is the Hb scavenger in the plasma of mammals, existing 
in humans as three primary phenotypes (Hp 1-1, Hp 2-1 and Hp 2-2) within a concentration range  
of 0.3–1.9 mg/mL [12,13]. These three Hp polymorphisms all contain the same Hb binding β globin 
(Hpβ), but differ in their α globin (Hpα1 or Hpα2) composition [14,15]. This results in dimeric (Hp 1-1) 
or multimeric (Hp 2-1, Hp 2-2) forms, as denoted by the number of α globin cysteines involved in 
disulfide bond formation. Several studies have shown that Hp prevents Hb renal excretion and 
subsequent kidney injury following experimental and clinical hemolysis [16–18]. In the present study, 
we evaluated the acute myocardial responses of guinea pigs challenged with LPS and Hb with or 
without the co-administration of purified multimeric human Hp. 
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2. Results 
2.1. Sequestration of Hb by Hp Prevents Renal Filtration 
A primary function of plasma Hp is to prevent renal excretion of Hb dimers [19]. To validate that 
the Hp administration conditions used in the present model effectively bound and maintained the 
extracellular Hb within a Hb-Hp complex, we first examined the renal deposition of non-heme iron as 
a marker of Hb exposure. Non-heme iron deposition was not observed in surgical control and  
LPS-infused animals using the Perls diaminobenzidine (DAB) intensification method (Figure 1A,B). 
However, Hb and LPS + Hb administered animals showed non-heme iron accumulation in the tubular 
epithelium of the renal cortex at 24 h post exposure. This was visualized as brown staining within 
hemosiderin granules (Figure 1C–E). Conversely, when LPS + Hb infusions were combined with 
concomitant Hp administration, no renal non-heme iron deposits were visualized (Figure 1F).  
Figure 1. Hp prevents renal exposure to Hb. Renal non-heme iron deposition was not 
detectable in surgical control animals (A) or with LPS alone (B). Animals infused with Hb 
alone (C) or LPS + Hb (D,E) demonstrated increased iron deposits in the tubular 
epithelium of the renal cortex (brown staining). The asterisk in Panels C and D denote the 
lumen of a representative tubule containing iron deposits. Administration of Hp with Hb 
following LPS prevented iron deposition (F). Panels A–D and F, 400×; Panel E, 600×.  
(G) SEC-HPLC chromatographs of plasma samples, purified Hb standard (red trace), and a 
purified Hb-Hp standard (blue trace). (H) Representative images of urine samples 1 h after 
dosing. Scale bars = 50 µm. 
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These findings are supported by size exclusion (SEC)-HPLC analysis of plasma samples collected  
1 h after dosing (Figure 1G). Representative samples from Hb and LPS + Hb administered animals 
demonstrated a single free Hb peak at an elution time of 21 min. This was confirmed by the elution 
time profile of the Hb standard solution. In the presence of Hp, Hb was completely bound and the 
elution time shifted to a broad band of peaks eluting over 13–17 min. This was also consistent with the 
elution time profile of the Hb-Hp standard. As a final confirmation, Hp sequestration of Hb was 
measured as the extent of hemoglobinuria over the initial hour after dosing (Figure 1H). Urinary Hb 
accumulation was only observed in Hb and LPS + Hb administered animals, but not in surgical 
controls, LPS or LPS + Hb + Hp administered animals. These data confirm that the Hp dose used in this 
study was effective in scavenging and maintaining all extracellular Hb within an Hp-bound complex.  
2.2. Hp Prevents Myocardial Iron Deposition and HO-1 Induction by LPS plus Hb 
Non-heme iron deposition was not observed in cardiac sections from surgical control or 
endotoxemic animals (Figure 2A–C). Infusion with Hb alone produced minor, but detectable, iron 
deposition in focal myocytes (Figure 2D). Animals infused with LPS followed by Hb showed diffuse 
regions of iron accumulation within myocytes at 24 h post-Hb infusion (Figure 2E,F). Non-heme iron 
staining was also observed in endothelial cells and perivascular regions of small and medium-sized 
cardiac blood vessels (Figure 2G,H). Conversely, the administration of Hp with Hb in endotoxemic 
animals prevented iron deposition in the contractile tissue of the heart and within myocardial blood 
vessels (Figure 2I). These data suggest that Hp attenuates extravascular translocation of Hb and iron 
deposition within the myocardium of endotoxemic animals. 
To further evaluate myocardial exposure to Hb, we examined HO-1 expression by Western blot.  
No significant changes in HO-1 expression were observed in animals infused with LPS or Hb alone 
(Figure 2J). In contrast, animals infused with LPS + Hb showed a six-fold increase in HO-1 expression 
24 h post-infusion compared to surgical controls. Co-administration of Hp with Hb prevented the 
increase in HO-1 expression.  
To identify the HO-1-expressing cells, myocardial sections were double labeled for HO-1 and 
CD163, a marker of monocytes/macrophages. In surgical controls, CD163+ perivascular cells that 
showed no HO-1 reactivity were detectable as flattened and elongated cells around small to  
medium-sized blood vessels (Figure 3A–C). In Hb infused animals, CD163+ perivascular cells were 
primarily negative for HO-1, although a few cells with a low level HO-1 reactivity were detectable 
(Figure 3D–F). In endotoxemic animals, CD163+ perivascular cells showed no HO-1 reactivity  
(Figure 3G–I). In contrast, LPS + Hb animals showed an increased accumulation of CD163+/HO-1+ 
cells around and within small to medium-sized myocardial blood vessels (Figure 3J–L) and in the 
adventitial regions of large epicardial blood vessels (Figure 3M–O). Hp administration attenuated the 
induction of HO-1 among CD163+ cells in the myocardium (Figure 3P–R) and around large blood 
vessels (Figure 3S–U). 
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Figure 2. Myocardial non-heme iron staining in surgical control animals (A,B), LPS alone 
(C), Hb alone (D), LPS + Hb (E-H), and LPS + Hb + Hp (I). High magnification of the 
boxed region shows cytoplasmic and nuclear iron staining in myocytes (brown) and 
surrounding myocytes containing only punctate nuclear iron deposits (F). Arrowheads show 
iron deposits in the perivascular regions and endothelium of cardiac blood vessels (G,H) 
(600×). Scale bars = 200 µm (A and E) or 25 µm (B–D, F–I). (J) Myocardial HO-1 
expression by Western blot. Representative blots for HO-1 and tubulin are shown. 
Densitometry values as a ratio to tubulin were normalized to non-treated controls (NT) and 
presented as the means ± SEM. * p < 0.05 vs. NT (n = 4 animals per group). 
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Figure 3. Immunofluorescence analysis of myocardial HO-1 and CD163 expression. 
Surgical non-treated (NT) control animals showed minimal HO-1 (green) expression in 
resident CD163+ perivascular macrophages (red) (A–C). Sporadic HO-1 expression (white 
arrow) localized to CD163+ cells observed with Hb alone (D–F). With LPS alone, CD163+ 
infiltrates and perivascular macrophages showed minimal HO-1 expression (white 
arrowhead) (G–I). Increased HO-1 expression localized to CD163+ infiltrates and 
perivascular macrophages observed with LPS + Hb (white arrows) (J–L,M–O). Hp 
reduces HO-1 expression in CD163+ infiltrates and perivascular cells (P–R,S–U). Nuclei 
were counterstained with Hoechst 33342 (blue). Scale bar = 10 µm. 
 
2.3. Hp Reduces Myocardial Myeloperoxidase Expression Induced by LPS plus Hb 
We next examined the myocardial expression of myeloperoxidase (MPO), an enzyme found 
primarily in neutrophils and macrophages that is considered a reliable marker of inflammation and 
oxidative stress [20]. Immunofluorescence analysis of MPO showed minimal staining in surgical 
controls and Hb infused animals (Figure 4A,B). MPO+ cells were detected sporadically in large 
myocardial blood vessels of endotoxemic animals (Figure 4C). Animals infused with LPS + Hb 
showed a higher incidence of MPO+ infiltrates primarily in the lumen and subendothelial layers of 
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blood vessels located in the ventricular myocardium (Figure 4D,E). Co-administration of Hp decreased 
the number of detectable MPO+ cells (Figure 4F). Western blot analysis of myocardial tissue extracts 
from animals infused with LPS or Hb alone showed no significant change in MPO expression 
compared to surgical controls (Figure 4G). In contrast, LPS + Hb induced a significant increase in 
MPO expression that was prevented with the co-administration of Hp. 
Figure 4. Immunofluorescence analysis of myocardial MPO expression in surgical control 
animals (A) and animals infused with Hb (B), LPS (C), LPS + Hb (D, E) or  
LPS + Hb + Hp (F). MPO+ infiltrates expressed red-stained azurophilic granules in the 
lumen (D) and subendothelial layers (E) of myocardial blood vessels. Asterisks in Panel D 
and E denote the lumen of a blood vessel. Nuclei were counterstained with Hoechst 33342 
(blue). Scale bar = 20 µm (A–D, F) or 10 µm (E). (G) Myocardial MPO expression by 
Western blot. Representative blots for MPO and tubulin are shown. Densitometry values as a 
ratio to tubulin were normalized to NT and presented as the means ± SEM. * p < 0.05 vs. NT, 
# p < 0.05 vs. LPS + Hb (n = 4 animals per group). 
 
2.4. Hp Protects against Myocardial Oxidative DNA Damage and Apoptosis Induced by LPS plus Hb 
To further investigate oxidative stress and injury in this model, we analyzed  
8-hydroxy-2'-deoxyguanosine (8-OHdG), a marker of oxidative DNA damage. Minimal 8-OHdG 
staining was detected in surgical controls or in animals infused with LPS or Hb alone (Figure 5A). 
Increased 8-OHdG reactivity was observed in animals infused with LPS + Hb, particularly in the 
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endothelial lining of many medium- to small-sized vessels in the ventricular regions of the 
myocardium. In LPS + Hb, but not LPS alone, perivascular macrophages and infiltrates also showed 
increased 8-OHdG reactivity. An increase in 8-OHdG reactivity was also evident in myocytes located 
in the vicinity of 8-OHdG positive blood vessels. Hp co-administration markedly reduced the extent of 
8-OHdG staining in cardiac blood vessels and within the myocardium (Figure 5A). 
Figure 5. (A) Immunofluorescence analysis of 8-hydroxy-2'-deoxyguanosine (8-OHdG) in 
myocardial sections of surgical control animals (NT), LPS, Hb, LPS + Hb and  
LPS + Hb + Hp. Pre-incubation of primary antibody with 8-OHdG (adsorption control) 
completely blocked the positive staining associated with the same blood vessel depicted in 
the LPS + Hb panel. (B) Representative images of TUNEL staining (red) and  
Hoechst-stained nuclei are shown. Quantification of TUNEL staining (total positive cells and 
late apoptotic cells) was performed as described in the Experimental Section. Means ± SEM 
for each group are shown. * p < 0.05 vs. NT, ** p < 0.05 vs. LPS + Hb. Scale bar = 50 µm. 
 
Toxins 2014, 6 1252 
 
 
To further evaluate DNA damage and apoptosis, myocardial sections were analyzed by the TUNEL 
assay (Figure 5B). Two types of TUNEL positive nuclei were distinguishable and quantified separately 
in these sections. The total positive cell index represented the nuclei with detectable TUNEL reactivity 
that showed no discernible changes in nuclear morphology. The late apoptotic (or necrotic) index 
represented the TUNEL-positive nuclei with confirmed nuclear condensation, disintegration  
or apoptotic body formation. In general, TUNEL-positive nuclei were evident among both myocytes, 
and non-myocyte (i.e., perivascular macrophages, endothelial cells) populations though the proportion 
of TUNEL-positive cells with a normal nuclear appearance were significantly greater than the 
confirmed late apoptotic (necrotic) cells. Infusion with LPS or Hb alone did not increase the total 
positive or late apoptotic cells compared to surgical controls. In contrast, LPS + Hb increased TUNEL 
reactivity among both the total positive cells and late apoptotic cells (Figure 5B). Hp administration 
significantly reduced TUNEL positivity induced by LPS + Hb. 
3. Discussion 
Studies in animal models of endotoxemia have reported that extracellular Hb exposure significantly 
increases lethality and may be associated with cardiovascular dysfunction [5,6]. The synergism 
between Hb and LPS is often attributed to Hb binding to LPS, causing disaggregation of LPS 
multimers and enhancing the exposure to LPS lipid A moieties [21,22]. Previous studies have also 
suggested that Hb augments LPS-induced TNF-alpha response in cultured monocytes and in vivo, an 
effect thought to contribute to the synergistic toxicity of Hb and LPS [23,24]. Enzymes, such as 
xanthine oxidase, phagocyte NADPH oxidase and MPO, have also been implicated in the 
overproduction of reactive oxygen species in sepsis and endotoxemia [25–29]. Several studies have 
investigated the role of MPO in monitoring cardiovascular disease primarily related to the 
inflammation observed in atherosclerosis [20], while the DNA oxidative product, 8-OHdG, is reported 
to be a relevant marker of sepsis-related oxidative stress and outcome [30]. In the context of the 
present study, we postulate that the oxidative microenvironment created by activated circulating 
inflammatory cells or tissue resident cells along the endothelial lining and within perivascular sites 
could be a major factor driving the oxidative reactions of Hb or its breakdown products [31]. 
Consistent with this view, the enhanced redox activity of various Hbs was shown to dramatically 
enhance LPS-induced apoptosis in endothelial cell culture [32]. Endothelial dysfunction is a hallmark 
of sepsis, which is often characterized by increased vascular permeability induced by LPS-mediated 
processes in several tissues, including the right and left ventricular coronary micro-vasculature [33,34]. 
Thus, LPS-induced loss of barrier function may represent a contributing mechanism underlying the 
extravasation of extracellular Hb or its breakdown products into perivascular sites. 
Consistent with these concepts, the present findings suggest that extracellular Hb exposure in 
endotoxemic guinea pigs can exacerbate inflammation, oxidative stress and cellular injury.  
These events are likely mediated by increased vascular permeability and perivascular myocardial 
exposure to free Hb or its breakdown products. We show that Hb infusion following LPS 
administration, but not either insult alone, increased myocardial iron deposition and HO-1 expression 
supporting the extravascular exposure to Hb with subsequent heme release. Enhanced  
MPO- and 8-OHdG-positive infiltrates, as well as 8-OHdG-positive perivascular and endothelial cells 
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of myocardial blood vessels are supportive of increased inflammation and oxidative stress. This is also 
consistent with the increased TUNEL reactivity observed in myocyte and non-myocyte populations. 
Hp is an important acute phase protein that initially increases in response to inflammation and 
infection. Other Hb detoxification proteins within this class also include hemopexin and ferritin, which 
participate in heme clearance and intracellular iron storage, respectively. Additional acute phase 
reactants relevant to infection and endotoxemia include: C-reactive protein, clotting factors, hepcidin 
and complement that participates in bacterial opsonization [35]. Our results demonstrate that the  
co-administration of Hp blocked the myocardial events induced by the combination of LPS and Hb. 
Several mechanisms may explain the protective activity of Hp. First, Hp may limit the translocation of 
Hb across the hyperpermeable endothelium. Second, Hp may prevent the release of heme into the 
myocardium and the vasculature, and third, Hp may control the redox activity of Hb driven by 
inflammation-derived hydro- and lipo-peroxides [36,37]. Together, the present data support a 
potentially useful therapeutic role for Hp in clinical or disease settings associated with the increased 
co-exposure to Hb and LPS, such as sepsis with concomitant trauma, surgery or blood transfusions. 
4. Experimental Section 
4.1. Reagents and Antibodies 
Stroma-free human Hb was purified from hemolysate to remove catalase by ion exchange 
chromatography on a diethylaminoethanol (DEAE) Sephadex column (GE-Healthcare, Sweden) and 
concentrated to 150 mg/mL in normal saline. Human multimeric phenotype specified product, absent 
dimeric Hp, was provided by Benesis Corporation (Osaka, Japan) at a concentration of 20 mg/mL in 
normal saline. Hp was then concentrated to 60 mg/mL. Standards of Hb-Hp complex for analytical size 
exclusion chromatography were separated from excessive (non-bound) Hb by gel chromatography on a 
HiLoad 26/60 Superdex 200 chromatography column (GE Healthcare Life Sciences, Piscataway, NJ, 
USA) and buffer exchanged into 50 mM phosphate-buffered saline (PBS). Rabbit polyclonal antibody 
to HO-1 was purchased from Enzo Life Sciences (Farmingdale, NY, USA). Mouse anti-CD163 clone 
EDHu-1 was obtained from AbD Serotec (Raleigh, NC, USA). Rabbit polyclonal anti-tubulin was 
obtained from Santa Cruz Biotechnologies (Santa Cruz, CA, USA). Rabbit polyclonal antibody to 
MPO was purchased from Cell Signaling Technology (Danvers, MA, USA). Rabbit monoclonal 
antibody to MPO was obtained from Abcam (Cambridge, MA, USA). Mouse monoclonal antibody to 
8-OHdG (clone N45.1) was purchased from Oxis International (Foster City, CA, USA). 
4.2. Animal Experimental Protocol 
Male Hartley guinea pigs (Charles Rivers Laboratories, Wilmington, MA, USA) were acclimated 
for one week upon arrival to the Food and Drug Administration (FDA) Center for Biologics Evaluation 
and Research (CBER) animal care facility. All animals weighed 400–450 g before surgery. Animal 
protocols were approved by the FDA CBER Institutional Animal Care and Use Committee, with all 
experimental procedures performed in adherence to the National Institutes of Health guidelines on the 
use of experimental animals. Surgical preparation was performed as previously described for 
implantation of indwelling venous and arterial catheters. After a 24 h period of post-surgical recovery, 
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animals were randomized to one of five groups as follows: (1) surgical non-treated control; (2) LPS 
(10 mg/kg, i.v.); (3) Hb (150 mg, i.v.); (4) LPS + Hb; and (5) LPS + Hb + Hp (150 mg Hb + 180 mg 
Hp, to ensure complete binding of Hb). All groups received equal infusion volumes normalized with 
0.9% NaCl. LPS was injected via an indwelling jugular catheter 2 h prior to administration of saline 
control, Hb or Hb + Hp. This LPS challenge produced sublethal endotoxemia allowing for the 
evaluation of Hb and Hb + Hp effects in the absence of mortality. In the three Hb infusion groups, the 
maximal plasma levels of Hb measured as heme equivalents were approximately 150 µM (260 mg/dL Hb). 
Blood (0.2 mL) was collected at baseline and after administration of control or test solution as 
follows: T = 0 (end administration), 0.5, 1, 2, 4, 6, 12 and 24 h (study termination). Urine was 
collected over the initial 4 h following administration of test or control solutions and at 24 h (study 
termination). Tissue harvesting was performed at 24 h following intraperitoneal administration of 
Euthasol (0.22 mg/kg) to induce deep anesthesia. Whole body perfusion was performed with 60 mL of 
cold 0.9% NaCl to remove blood from major organ systems. Heart was cut into two longitudinal 
sections starting at the apex through the septum to the aortic root to expose the right and left 
ventricular walls and the septum. Similarly, right and left kidneys were cut into two longitudinal 
sections to expose the cortex and medulla. Half of the tissue was fixed in formalin, and half was snap 
frozen in liquid nitrogen. 
4.3. Plasma Hemoglobin Distribution 
Following administration, Hp bound and unbound fractions of Hb were determined by size 
exclusion high performance liquid chromatography (SEC-HPLC) using a Waters 600 controller,  
a Waters 600 pump and a Waters 2499 photodiode array detector (Waters, Corp, Millford, MA, USA). 
Plasma samples were separated on a BioSep-SEC-S3000 (600 × 7.5 mm) column (Phenomenex, 
Torrance, CA, USA) with 50 mM potassium phosphate, pH 7.4 as the mobile phase. Column injections 
were maintained at consistent volumes using a 50-μL injection loop. All samples were monitored at  
λ = 280 nm and λ = 405 nm in dual wavelength mode. Hb bound and unbound in plasma was 
determined by dividing the Hb peak area and the Hb-Hp peak area by additive areas under the  
Hb-Hp chromatographic peak (13–17 min elution) and the Hb chromatographic peak (21 min elution) 
at λ = 405 nm. 
4.4. Non-heme Iron Immunohistochemistry 
Hearts and kidneys were fixed in 10% formalin for 24 h, then stored in 100% isopropanol, 
embedded in paraffin, and 5 µm sections were prepared. Non-heme ferric iron deposition was detected 
using Perls’ method with DAB intensification. Sections were dewaxed in Safe Clear™ (Houston, TX, 
USA) and rehydrated in graded ethanol and deionized water. Tissues were then incubated with Perls’ 
iron reagent containing 5% potassium ferrocyanide and 2% hydrochloric acid for 45 min at room 
temperature and rinsed in deionized water. Sections were then incubated with 0.3% hydrogen peroxide 
and 0.01 M sodium azide in methanol for 30 min at room temperature. All sections were then rinsed  
in 0.1 M phosphate buffer, pH 7.4, incubated with DAB for three minutes, washed in deionized water 
and lightly counterstained with Gill’s II hematoxylin. After dehydrating in graded ethanol and 
Toxins 2014, 6 1255 
 
 
Safeclear, slides were mounted in Permount and coverslipped. Images were obtained using an 
Olympus IX71 inverted microscope. 
4.5. Preparation of Heart Tissue Lysates 
Frozen heart samples from the ventricular compartment were dounce-homogenized in the presence 
of ice-cold modified radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris, 150 mM sodium 
chloride, 1% IgePal®-630, 0.5% sodium deoxycholate, 1 mM ethylenediaminetetraacetic acid (EDTA) 
containing protease inhibitors (Cocktail Set III, Calbiochem, CA, USA). Lysates were centrifuged at 
10,000 rpm at 4 °C for 30 min. Supernatants were collected and stored at −80 °C. Protein 
concentrations were measured using the bicinchoninic acid (BCA) protein assay (Thermo Scientific, 
Rockford, IL, USA). 
4.6. Western Blot Analyses 
Heart lysates were resolved on 4%–12% Bis-Tris gels, transferred to polyvinylidene fluoride 
(PVDF) membranes and blocked for 1 h in Tris buffered saline with 0.1% Tween-20 (TBS-T) and 5% 
nonfat dry milk. Membranes were incubated overnight at 4 °C with antibodies to HO-1 (1:2500) and 
MPO (1:2000) in TBS-T with 1% nonfat dry milk or 3% bovine serum albumin (for MPO), washed 
and then incubated with a relevant horseradish peroxidase (HRP)-conjugated secondary antibody for 1 
h. The signal was developed using the ECL Plus chemiluminescence kit (Amersham, Arlington 
Heights, IL) and detected on HyperECL film. Densitometry analysis was performed using ImageJ 
software (National Institutes of Health, Bethesda, MD, USA) with normalization to tubulin. 
4.7. Immunofluorescence 
Paraffin-embedded slides were dewaxed and rehydrated. Slides were heat-treated in a microwave 
oven for 15 min in 10 mM sodium citrate buffer, pH 6.0, cooled for 30 min at room temperature and 
rinsed with deionized water and PBS-T. Sections were then blocked in PBS-T with 5% goat or horse 
serum for 1 h at room temperature followed by overnight incubation at 4 °C with antibodies to HO-1, 
MPO, CD163 and 8-OHdG. Sections were rinsed and incubated with relevant Alexa-Fluor 488- and 
Alexa-Fluor 555-conjugated secondary antibodies for 1 h at room temperature. Nuclei were 
counterstained with Hoechst 33342. For double labeling experiments, primary antibodies were mixed 
together and incubated overnight at 4 °C. Sections stained with secondary antibodies alone showed no 
specific staining. Images were processed using an Olympus IX71 inverted microscope equipped with 
an Olympus DP70 digital camera. 
4.8. TUNEL Assay 
Hearts were removed and fixed in neutral buffered 10% formalin at room temperature for 24 h 
before embedding in paraffin and sectioning. Sections were deparaffinized, antigen retrieved with 
proteinase K treatment (20 µg/mL for 20 min at room temperature) and then subjected to TUNEL 
(terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling) staining according to the 
manufacturer’s instructions (Apotag Red In Situ Apoptosis Detection kit, Millipore, Billerica, MA, 
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USA). Negative controls performed in the absence of the terminal deoxynucleotidyl transferase TdT 
enzyme showed no TUNEL reactivity. The TUNEL-positive nuclei and the total number of nuclei were 
counted in 6 fields of view per slide captured at 400× magnification. The average number of nuclei 
counted per field for each group was as follows; non-treated controls (175 ± 4), Hb (170 ± 13), LPS 
(162 ± 17), LPS + Hb (179 ± 7) and LPS + Hb +Hp (188 ± 10). The TUNEL-positive cell index was 
calculated as the number of nuclei with detectable TUNEL reactivity regardless of staining intensity or 
nuclear morphology divided by the total number of nuclei. The late apoptotic index was calculated as 
the number of TUNEL-positive nuclei with confirmed nuclear condensation or disintegration divided 
by the total number of nuclei. 
4.9. Statistical Analysis 
Data are represented as the means ± SEM for replicate experiments. Statistical analysis was 
performed by one-way ANOVA with a post-hoc Bonferroni’s test for all normally distributed, equal 
variance and equal number comparisons. A non-parametric one-way ANOVA was performed for 
comparisons with unequal distributions and non-matched group sizes. All analyses were performed 
using GraphPad Prism version 5 software. A p-value < 0.05 was considered statistically significant. 
5. Conclusions 
Extracellular Hb enhances the markers of iron deposition, inflammation, oxidative stress, and cell 
death in the myocardium of endotoxemic guinea pigs. The co-administration of Hp, a Hb scavenger 
protein, attenuated the myocardial events observed. These findings suggest that the synergistic toxicity 
induced by the co-exposure to LPS and Hb may be counteracted by therapeutic approaches designed to 
prevent or eliminate the accumulation of free Hb. This may have important implications for the 
management of sepsis and/or septic shock with concomitant trauma, surgery, or blood transfusions. 
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